Treatment of cutaneous leishmaniasis by intralesional metronidazole.
Al-Waiz
Makram
M
Department of Dermatology and Venereology, College of Medicine, University of Baghdad, Baghdad, Iraq. makram552000@yahoo.com
Sharquie
Khalifa E
KE
Al-Assir
Mohammad
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015552:Injections, Intralesional; D007493:Iraq; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage*; D008875:Middle Aged; D011446:Prospective Studies; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D008795:Metronidazole